跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 108,202 条关于
“Programmed Cell Death 1 Ligand 1”
全部
108,202
临床试验
72,183
药物
11,508
机构
1,525
资讯
22,986
2年前
Endometrial Cancer Clinical Trial Landscape Shows Increasing Global Activity
2年前
Optimizing Outcomes for High-Risk, Non-Muscle-Invasive Bladder Cancer with PD-(L)1 Inhibitors
去年
Hansoh Pharma's HS-20093 ADC Granted Breakthrough Therapy Designation for SCLC in China
2年前
Low Incidence of Cardiovascular Events with Immune Checkpoint Inhibitors Reported in Meta-Analysis
去年
Empagliflozin's Cardiorenal Benefits Persist One Year After Discontinuation: EMPA-KIDNEY Follow-Up
去年
Ligand-Independent Strategies May Overcome Challenges in TREM-1 and TREM-2 Inhibition
2年前
Advancements in Immune Checkpoint Inhibition for Hepatocellular Carcinoma Treatment
去年
FDA Approves Checkpoint Therapeutics' Unloxcyt (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma
去年
China Approves MSD's Welireg (belzutifan) for VHL-Associated Tumors
8天前
Immunotherapy, Not Chemotherapy, Drives Hair Repigmentation in Thoracic Cancer Patients
第 1 页，共 2299 页
上一页
下一页
